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Atrial fibrillation (AF) is the most common progressive disease in patients with cardiac arrhythmia. AF is accompanied by complex atrial
remodeling and changes in gene expression, but only a limited number of transcriptional regulators have been identified. Using a low-density cDNA
array, we identified 31 genes involved in transcriptional regulation, signal transduction or structural components, which were either significantly
upregulated or downregulated in porcine atria with fibrillation (induced by rapid atrial pacing at a rate of 400–600 bpm for 4 weeks that was then
maintained without pacing for 2 weeks). The genes for four and a half LIM domains protein-1 (FHL1), transforming growth factor-β (TGF-β)-
stimulated clone 22 (TSC-22), and cardiac ankyrin repeat protein (CARP) were significantly upregulated, and chromosome 5 open reading frame gene
13 (P311) was downregulated in the fibrillating atria. FHL1 and CARP play important regulatory roles in cardiac remodeling by transcriptional
regulation and myofilament assembly. Induced mRNA expression of both FHL1 and CARPwas also observed when cardiac H9c2 cells were treated
with an adrenergic agonist. Increasing TSC-22 and marked P311 deficiency could enhance the activity of TGF-β signaling and the upregulated
TGF-β1 and -β2 expressions were identified in the fibrillating atria. These results implicate that observed alterations of underlying molecular
events were involved in the rapid-pacing induced AF, possibly via activation of the β-adrenergic and TGF-β signaling.
© 2006 Elsevier B.V. All rights reserved.Keywords: Atrial fibrillation; Low-density cDNA array; Transcriptional regulator; Transforming growth factor-β signaling1. Introduction
Atrial fibrillation (AF), the most common sustained arrhyth-
mia, causes progressive alterations in atrial electrical, contractile
and structural properties, which are associated with changes in
cardiac gene expression [1,2]. Recent studies have focused on
the molecular basis of atrial remodeling using candidate gene
and genome-wide approaches in AF patients [3–5]. Gene
expression profiling studies on dedifferentiation [3], apoptosis
[5], fibrosis and thromboembolic events [4] have highlighted the
complex regulation of gene expression during AF formation and
maintenance. However, thus far, transcriptional regulators
involved in regulating transcription in AF have been proposed⁎ Corresponding author. Tel.: +886 3 5131338; fax: +886 3 5729288.
E-mail address: lincs.biotech@msa.hinet.net (C.-S. Lin).
0925-4439/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2006.10.017[6], but attempts to identify the regulators have been lacking.
Activation of transcriptional regulators during AF may coordi-
nately lead to sequential transcriptional control events that
regulate the phenotype of cardiomyocytes in response to AF
disease conditions [6]. In fact, AF is often associated with other
cardiovascular diseases such as hypertension, thyrotoxic heart
disease, coronary artery disease, rheumatic valve disease, and
heart failure [7]. Moreover, changes in gene expression in
clinical AF may be the result of AF combined with other
underlying heart diseases [4]. Therefore, functional studies of
transcriptional regulators in rapid pacing-induced AF or
transgenic animal AF models [8] may clarify the underlying
molecular mechanisms of AF because the potential confound-
ing effects of other underlying heart diseases have been
eliminated.
In the present study, we investigated 84 candidate genes
specifically associated with fibrillating atria of a porcine AF
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Three genes, four and a half LIM domains protein-1 (FHL1),
transforming growth factor beta-stimulated clone 22 (TSC-22)
and cardiac ankyrin repeat protein (CARP), encoding transcrip-
tional regulators, were significantly upregulated, and chromo-
some 5 open reading frame gene 13 (P311), an anti-fibrotic gene,
was downregulated in the fibrillating atria. Along with
confirmation of the selected genes for differential expression
profiles, the further identification of protein expression and
implicated mechanism in the fibrillating atria were subsequently
evaluated. The results provide more insights into the underlying
molecular events in pacing-inducedAF and evidence of complex
transcriptome changes that may accompany AF development.
2. Materials and methods
2.1. AF induced by rapid atrial pacing
A porcine model of AF was used as described previously [9]. Eighteen adult
Yorkshire-Landrace strain pigs were used (12 in the AF group and 6 in the sham
control group), with mean body weight 62±5 kg. In this study, six pigs in the AF
group were added besides the specimens of 6 AF and 6 sham control that were
sampled in our previous study [10]. The experimental protocol conformed to the
Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23,
revised 1996) and was approved by the Institutional Animal Care and Use
Committee of the National Taiwan University College of Medicine. All pigs
were provided by the Animal Technology Institute in Taiwan (ATIT) and housed
at the animal facility in the ATIT. Each animal was transvenously implanted with
either a high-speed atrial pacemaker (Itrel-III; Medtronic Inc., Minneapolis,
MN) for the AF group or an inactive pacemaker for the sham control group (i.e.,
sham hearts maintained normal sinus rhythm, SR). The atrial pacing lead
(Medtronic) was inserted through the jugular vein and screwed to the right
atrium. The atrial high-speed pacemaker was programmed to a rate of 400–600
beats per min for 4 weeks in the AF group. After continuous pacing, the atrial
pacemaker was turned off and the animals remained in AF. The animals were
sacrificed 2 weeks after the pacemaker was turned off, and thus the total duration
of atrial depolarization was 6 weeks. In the sham control group, the pacemaker
remained off for the entire 6 weeks after implantation.
2.2. Tissue processing
The pigs were anaesthetized and sacrificed at the end of the experimental
period. The right atrial appendages (RAA) and left atrial appendages (LAA)
were excised and immediately frozen in liquid nitrogen and then stored at
−80 °C until use for RNA or protein extraction for later experiments.
2.3. RNA isolation
Total RNA was extracted and quantified from the pig LAA and RAA
according to our previous report [11]. In brief, 200 mg of atrial tissue was
homogenized on ice by a rotor–stator-type tissue homogenizer in 1 ml TRIzol
reagent (GIBCO BRL, Gaithersburg, MD). Cellular debris was removed by
centrifugation for 10 min at 12,000×g at 4 °C, and RNA was precipitated by
adding equal volumes of isopropanol and then washing with 75% ethanol. The
resultant RNAwas further purified with the RNeasy Midi kit (Qiagen, Valencia,
CA) according to the manufacturer's instructions. The amount of total RNAwas
determined spectrophotometrically at 260 nm, and the integrity was confirmed
by analysis on a denaturing agarose gel. The RNA was used in the cDNA
microarray and quantitative real-time RT-PCR analysis.
2.4. Specialized AF Chip design and preparation
A total of 84 gene sequences were selected for a low-density cDNA array,
named the AF Chip. Selection of these genes was based on the following threeconsiderations: the gene had been reported to be associated with a
cardiomyopathy [12], the gene was significantly and differentially expressed
in fibrillating tissue of a rapid pacing-induced AF model in our previous report
on a microarray containing 6032 human cDNA clones (UniversoChip,
AsiaBioinnovations, Newark, CA) [10], and the gene clone was available
from the IMAGE consortium (Open Biosystems, Huntsville, AL). All symbols
and accession numbers of the selected genes used in the AF Chip are shown in
Fig. 1. Additionally, two control cDNAs, glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) and β-tubulin, as well as pUC19, were included in the
chip. The selected clones were purchased from IMAGE consortium, and the
sequences were verified in our laboratory. The clones were amplified using PCR
with 36 cycles of a denaturing temperature of 95 °C for 30 s, annealing
temperature of 55 °C for 30 s, and extension temperature of 72 °C for 45 s. The
commercial primers for amplification were as follows: T7 primer (5′-TAATAC
GAC TCA CTATAG GG-3′), Sp6 primer (5′-CATACG ATT TAG GTG ACA
CTA TAG-3′), T3 primer (5′-AAT TA A CCC TCA CTA AAG-3′), M13
forward primer (5′-GTA AAA CGA CGG CCA G-3′), and M13 reverse primer
(5′-CAG GAA ACA GCT ATG AC-3′) (Invitrogen, Carlsbad, CA). After
amplification, the quality and specificity of the PCR products were confirmed by
agarose gel electrophoresis.
PCR-amplified DNA products were mixed with dimethyl sulfoxide (1:1, v/v)
and then spotted onto amino-coated glass slides (TaKaRa Mirus Bio Inc.,
Madison, WI) using a robotics SpotArray 24 (PerkinElmer Life Sciences,
Boston, MA). To evaluate the reliability of the AF Chip, PCR-amplified DNA
productswere spotted in duplicate onto a slide. SpottedDNAwas crosslinked and
denatured according to the manufacturer's instructions (Takara Mirus Bio Inc.,
http://www.takaramirusbio.com).
2.5. Hybridization and imaging of fluorescently labeled cDNA
Twenty μg of total RNA extracted from the SR and AF subjects was
reverse-transcribed with an oligo-dT primer to prepare fluorophore-labeled SR
and AF cDNA with Cyanine-3 dUTP (Cy3) and Cyanine-5 dUTP (Cy5)
(PerkinElmer Life Science, Boston, MA), respectively. Fluorophore-labeled
cDNA pairs were precipitated together with ethanol and purified using
Microcon YM-30 purification columns (Millipore, Bedford, MA). The labeled
cDNAs were resuspended in the hybridization buffer of 20% formamide, 5×
SSC, 0.1% SDS and 0.1 mg/ml salmon sperm DNA (Ambion, Austin, TX),
and then denatured by heating at 95 °C for 3 min. The mixture of labeled
cDNA pairs was applied to the AF Chips under a 22-mm2 cover slip and
allowed to hybridize for 16 h at 55 °C in a hybridization chamber
(GeneMachines, San Carlos, CA). The chips were washed at 45 °C for
10 min in 2× SSC, 0.1% SDS, followed by two washes at room temperature in
1× SSC (10 min) and 0.2× SSC (15 min). After hybridization, the slides were
scanned with a dual-laser scanner GenePix 4000B at 10-μm resolution (Axon
Instruments Inc., Union, CA). Results of the competitive hybridization were
imaged at different photomultiplier settings to yield a balanced and applicable
signal. Spots with saturated signal intensity or with signal less than background
were excluded from the final data set. The data were converted from image to
signal using GenePix Pro 4.1 software (Axon Instruments Inc.) for further
statistical analysis.
2.6. Data analysis and gene ontology
The fluorescence intensity of the local mean background was calculated for
each spot, and we accepted only those cDNA spots with a fluorescence signal
intensity more than the mean local background plus 2 standard deviations (SD)
and greater than the intensity of the negative control. The signals from all the
experimental arrays were normalized based on the GAPDH probe sets in which
the average signal from GAPDH (as an internal control) was defined as
unchanged. On the same AF Chip, the two intensity values of the duplicate
cDNA clone spots were averaged and used to determine the ratio between the
AF and sham control subjects (i.e., the ratio of Cy5/Cy3 intensities). Genes were
classified as differentially expressed when the value of the mean ratios was≥1.5
or ≤0.67. Functional classification of the differentially expressed genes was
according to the GeneCards web site (http://www.genecards.org/ index.shtml)
and the Gene Ontology Consortium (http://www.geneontology.org).
Fig. 1. Design of the AF Chip. The 84 selected cDNA clones are members of the following functional classes: extracellular matrix, structural components, signal
transduction, metabolism, ion transporters, cell proliferation, transcription regulation, EST sequences, and others. Two housekeeping genes, β-tubulin and GAPDH,
were spotted onto the slides for signal normalization and positive controls. To evaluate the reliability of the experimental hybridization, a blank and a negative control
(pUC19) were also included in the chip.
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SYBR Green quantitative real-time reverse transcription-PCR (RT-PCR)
was performed on the genes FHL1, TSC-22, CARP, P311, TGF-β1,-β2,-β3 and
GAPDH (as an internal control) to confirm the results obtained by the AF Chip
and TGF-β isoforms mRNA expression. The specific forward and reverse
primers were designed with Primer Express software (PE Applied Biosystems,
Foster, CA) (Table 1). The cDNAwas synthesized by extension with oligo (dT)
primer at 42 °C for 60 min in a 25-μl reaction containing 5 μg total RNA, 1×
First-Strand Buffer (75 mM KCl, 3 mM MgCl2, 50 mM Tris–HCl, pH 8.3),
8 mM DTT, 10 μM dNTPs, 20 U RNase inhibitor, and 200 U Superscript II
reverse transcriptase (Invitrogen). For each selected gene, the primer sets were
tested for quality and efficiency to ensure optimal amplification of the samples.
Real-time RT-PCR was performed at 1, 1/4, 1/16, 1/64, 1/128, and 1/512
dilution of the synthetic cDNAs to define relative fold changes. Real-time RT-
PCR reactions contained 12.5 μl SYBR Green PCR master mix (PE Applied
Biosystems), 2 μl forward primer (10 μM), 2 μl reverse primer (10 μM), 3 μl
cDNA, and 5.5 μl distilled water. All PCR reactions were carried out in triplicate
with the following conditions: 2 min at 50 °C, 10 min at 95 °C, followed by 40
cycles of 15 s at 95 °C, 30 s at 57 °C, and 30 s at 60 °C in a 96-well optical plate
(PE Applied Biosystems) in the ABI 7000 Sequence Detection System (PE
Applied Biosystems). A PCR reaction without cDNA was performed as a
template-free negative control. According to the instructions of PE Applied
Biosystems, the expression of each gene was quantified as ΔCt (Ct of target
gene−Ct of internal control gene) usingGAPDH as the control and applying the
formula 2−ΔΔCt to calculate the relative fold changes [13].2.8. Protein preparation and western blot analysis
Western blotting was performed to determine the protein levels of FHL1
and CARP in the atrial AF and SR tissues. Frozen atrial tissues (about
200 mg) were homogenized in 1 ml of ice-cold lysis buffer containing
20 mM Tris–HCl, pH 7.6, 1 mM dithiothreitol, 200 mM sucrose, 1 mM
EDTA, 0.1 mM sodium orthovanadate, 10 mM sodium fluoride, 0.5 mM
phenylmethylsulfonyl fluoride and 1% (v/v) Triton X-100. The homogenates
were then centrifuged at 10,000×g for 30 min at 4 °C. Supernatants were
collected and protein concentration was measured with the Bio-Rad protein
assay (Bio-Rad Laboratories, Hercules, CA). Equal amounts of protein
(20 μg/lane) were separated on 10% polyacrylamide gels by SDS-PAGE and
transferred onto polyvinylidene fluoride membranes (Millipore) at 50 mA for
90 min in a semi-dry transfer cell (Bio-Rad). Membranes were blocked for
60 min in TBS (10 mM Tris–HCl, 0.15 M NaCl, pH 7.4) containing 5%
nonfat dry milk with gentle shaking. Following three washes with TBS
containing 0.1% (v/v) Tween-20 for 5 min, the membrane was incubated with
anti-human FHL1 (1:5000), anti-human CARP (1:5000), or anti-human β-
tubulin (1:5000; all three antibodies were from Santa Cruz Biotechnology,
Santa Cruz, CA), and detected using horseradish peroxidase-conjugated anti-
goat IgG and ECL western blotting detection reagents (Amersham Pharmacia
Biotech, Little Chalfont, UK) according to the manufacturer's instructions.
The images were scanned, and densities of each band were analyzed by
Scion image software (National Institutes of Health, Bethesda, MD). The
relative protein expression of FHL1 and CARP was normalized to β-tubulin
expression.
Table 1
Primers for quantitative real-time RT-PCR
Gene name (Gene symbol/Accession no.) Primer a Sequence (5′→3′) Amplified length (bp)
Four and a half LIM domains 1 (FHL1/ NM_214375) Forward CTG CGT GGATTG CTA CAA GA 115
Reverse GTG CCA GGATTG TCC TTC AT
Transforming growth factor beta-stimulated clone 22 (TSC-22/ NM_006022) Forward CCA TGA AGG TTG TTT TGC T 130
Reverse ACC TCC TCA GAC AGC CAAT
Cardiac ankyrin repeat protein (CARP/ NM_213922) Forward CTT CCC GTA GGT AGC TCT TA 122
Reverse GCA ACA ATC ATC CCC TCT G
Chromosome 5 open reading frame 13 (P311/ NM_004772) Forward GCG AGG TAG CTC TGATGG A 123
Reverse GCC ACA CTG AAG ACA CAA GG
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH/AF017079) Forward AGA AGA CTG TGG ATG GCC C 110
Reverse ATG ACC TTG CCC ACA GCC T
Transforming Growth Factor β1 (TGF β1/ NM_214015) Forward GGC CGT ACT GGC TCT TTA CA 138
Reverse TAG ATT TGG TTG CCG CTT TC
Transforming Growth Factor β2 (TGF β2/ L08375) Forward ATG GCA CCT CCA CAT ATA CCA 101
Reverse GGG CAA CAA CAT TAG CAG GA
Transforming Growth Factor β3 (TGF β3/ NM_214198) Forward AAG AAG GAA CAC AGC CCT CA 116
Reverse GCG GAA GCA GTA GTT GGT GT
a Primer sequences for each target gene were selected to minimize the formation of self-complementarity and hairpins using the software Primer Express (PE
Applied Biosystems).
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Fresh tissues of atrial appendages were cut into 3–5 mm slices and fixed in
4% (v/v) formalin buffer containing 0.1 M sodium phosphate (pH 7.5) before
paraffin embedding. Tissue blocks were treated into 6 μm sections and
deparaffinized for hematoxylin–eosin and Masson's trichrome blue staining.
2.10. Immunohistochemical assay
Immunohistochemical assay was performed on 6 μm sections that were
rehydrated and blocked with 10% (v/v) normal goat serum (Santa Cruz
Biotechnology). Subsequently, the sections were incubated overnight at 4 °C
with anti-FHL1 or-CARP specific antibodies (Santa Cruz Biotechnology) in
Tris-buffered saline (10 mM Tris–HCl, pH 8.0, 150 mM NaCl), followed by
incubations with biotinylated secondary antibodies that were detected with
streptavidin–horseradish peroxidase conjugates (Vectastain Elite ABC kit;
Vector Laboratory, Burlingame, CA). Peroxidase activity was visualized with
diaminobenzidine and hydrogen peroxide. For detection, a control was done by
omitting the primary antibody to determine the nonspecific binding. Nuclei were
counterstained with hematoxylin.
2.11. Cell culture and treatment
H9c2 cardiomyocytes (ATCC; CRL1446) were plated at 60% confluence in
Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal calf
serum (FCS), 2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml
streptomycin (growth-promoting medium). The medium was switched to
DMEM containing 1% FCS for 48 h (differentiation-promoting medium) when
the H9c2 cells had grown to 70–80% confluence. The cells were then treated
with 1 μM angiotensin II (Ang II) (Sigma, St. Louis, MO), 10 μM isoproterenol
(Sigma), 0.2 mM H2O2 (Merck, Darmstadt, Germany), or the same volume of
Dulbecco's PBS (DPBS; control treatment). The treated cells were harvested
12 h after treatment, and total RNA was isolated as described above.
2.12. Semi-quantitative RT-PCR
Unique PCR primers specific forFHL1 (5′-AGGGGAGGACTTCTACTG
TGTG-3′ and 5′-CCAGAT TCA CGGAGCATT TT-3′), CARP (5′-AAATCA
GTGCCCGAGACAAG-3′ and 5′-ATT CAACCT CAC CGCATCA-3′) and
GAPDH (5′-GGT GAT GCT GGT GCT GAG TA-3′ and 5′-TTC AGC TCT
GGG ATG ACC TT-3′) were designed using PRIMER3 software (available
online at http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and the
nucleic acid sequence database from the National Center for BiotechnologyInformation (NCBI). Total RNA from H9c2 cells was prepared as described
above. The cDNA was synthesized by Superscript II reverse transcriptase
(Invitrogen) from 5 μg of total RNA. The PCR reaction contained 3 μl cDNA,
2 μl forward and reverse primers (10 μM), 5 μl 10× PCR buffer, 2 μl 10 mM
dNTPs, 1 μl of 5 U/μl Taq polymerase (Promega, Madison, WI) and 37 μl
distilled water in a total volume of 50 μl. DNA was amplified by an initial
incubation at 94 °C for 3 min followed by 25–30 cycles of 94 °C for 30 s, 60 °C
for 30 s, 72 °C for 30 s, and a final extension at 72 °C for 6min. The PCRproducts
were separated by electrophoresis in a 2% agarose gel, visualized by ethidium
bromide staining, and the band intensity was quantified using an image analyzer
(Kodak DC290 Digital camera System; Eastman Kodak, Rochester, NY). The
relative amount of mRNAwas measured using densitometric analysis by Scion
image (National Institutes of Health) and normalized to the level of GAPDH
mRNA.
2.13. Statistical analysis
Experimental results are expressed as means±SD. Data from the AF Chip,
real-time RT-PCR, semi-quantitative RT-PCR and western blots were analyzed
using the Student's t test. Differences with P<0.05 were considered significant.
3. Results
3.1. Quality assessment of the AF Chip hybridization
In our previous study using a high-density cDNA micro-
array, many genes demonstrated marked expression changes in
the fibrillating atria of a rapid pacing-induced AF model [10].
However, the genes involved in signal transduction and trans-
criptional regulation during AF have not been evaluated in
detail. Therefore, we constructed a low-density cDNA array, the
AF Chip, which included genes in these functional pathways
and others to investigate changes in gene expression in atrial
tissues during AF. The chip was fabricated with 84 AF or heart
diseases-related genes mentioned in published papers, including
our own previous report [10], to further analyze their relation-
ship with AF.
To validate the reproducibility and quality of the AF Chip, we
analyzed correlation factors from the intensity values of each
gene in duplicated spots and replicated hybridizations. The
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spots in a representative hybridization (Fig. 2A) fit a linear line
with correlation factors of 0.985 and 0.981 in the Cy5 (in red;
Fig. 2B) and Cy3 (in green; Fig. 2C) channels, respectively. In
the AF Chip experiments, two independent hybridizations were
performed for each sample, and the mean intensity values for
each gene from one chip were plotted against those from the
second chip. After normalization, the correlation factors of the
12 replicate hybridization data with Cy3 and Cy5 normalized
intensities ranged from 0.921 to 0.993 (average of 0.964 in the
Cy3 channel and 0.947 in the Cy5 channel). The results
demonstrate that the AF Chip data were reproducible. Moreover,
these high correlation factors indicate that the AF Chip was
consistent and reliable.
3.2. Genes with altered expression in AF
Following competitive hybridization using labeled cDNAs
from individual RAA tissues of AF and SR, the ratio of
expression of each gene (Cy5 signal intensity in AF, and Cy3
signal intensity in SR) was averaged and evaluated by the
Student's t test. The 31 genes with significantly altered mRNAFig. 2. Quality assessment of the AF Chip. A representative result from the AF Chip i
(control) subjects. Message RNA from SR tissue was used to prepare cDNA labeled w
with Cy5. The two cDNA probes were mixed and simultaneously hybridized to the AF
indicates genes whose mRNAs were more abundant in SR. Yellow spots represent gen
plot analyses of spot intensities between duplicate spots with the Cy5 (B) and Cy3 (C)
reader is referred to the web version of this article.)expression in rapid-pacing induced AF were shown in Table 2.
These genes were classified into seven functional categories
according to the molecular and biological function of their
encoded protein. The categories include transcription (4 genes),
structural components (8), metabolism (4), signal transduction
(3), cell proliferation (2), and others (10, including ESTs), among
which, two genes encoding proteins associated with the
myofibrillar apparatus, myosin regulatory light chain-2 (MLC-
2V) and cysteine and glycine-rich protein 1 (CSRP1), showed a
4.4- and 2.6-fold increase in AF, respectively. Several genes
encoding components of the extracellular matrix were differen-
tially expressed in AF, like increased expression of spondin 1
(SPON1), fibronectin 1 (FN1), cadherin 2 (CDH2) and a
disintegrin and metalloprotease domain 10 (ADAM10), and
decreased expression of cartilage-associated protein (CRTAP)
and matrix metalloproteinase 11 (MMP-11). Genes involved in
signal transduction pathways, including calmodulin 2 (CALM2),
beta-2 adrenergic receptor (β2AR) and insulin-like growth factor
binding protein 5 (IGFBP5), showed upregulation. Among the
unclassified genes, the marked downregulation of P311 in
fibrillating atria is particularly interesting because of its putative
anti-fibrotic function. There were four genes, FHL1, CARP,s shown (A). AF Chip hybridization comparing mRNA isolated from AF and SR
ith Cy3, and mRNA extracted from AF tissue was used to prepare cDNA labeled
Chip. Red indicates genes whose mRNAs were more abundant in AF, and green
es whose expression did not vary substantially between the two samples. Scatter-
channels. (For interpretation of the references to colour in this figure legend, the
Table 2
Genes with significantly altered expression in the right atrial appendages with sustained AF as assayed by the AF Chip
Accession no. Function/Gene name Symbol Ratio (Cy5/Cy3) SD P value
Transcription-related genes
AA725097 Four and a half LIM domains 1 FHL1 3.17 ↑ 1.27 0.001
NM_006022 Transforming growth factor TSC-22 TSC-22 3.09 ↑ 1.71 0.011
AA521128 Transcription elongation factor B (SIII) TCEB1 2.49 ↑ 1.10 0.001
X83703 Cardiac ankyrin repeat protein CARP 1.61 ↑ 0.45 0.001
Structural components and extracellular matrix-related genes
S69022 Myosin regulatory light polypeptide 2 MYL2 4.35 ↑ 1.70 0.001
BE388159 Cysteine and glycine-rich protein 1 CSRP1 2.57 ↑ 1.81 0.012
AI809596 Spondin 1 SPON1 2.05 ↑ 1.13 0.017
X02761 Fibronectin 1 FN1 1.94 ↑ 0.72 0.001
M34064 Cadherin 2 CDH2 1.76 ↑ 0.77 0.005
AA043347 A disintegrin and metalloprotease domain 10 ADAM10 1.50 ↑ 0.77 0.044
AA451883 Cartilage associated protein CRTAP 0.63 ↓ 0.49 0.025
AI189375 Matrix metalloproteinase 11 MMP11 0.48 ↓ 0.38 0.001
Signal transduction-related genes
D45887 Calmodulin 2 CALM2 1.71 ↑ 0.66 0.004
U02390 Beta-2 adrenergic receptor B2AR 1.64 ↑ 0.73 0.030
AW157548 Insulin-like growth factor binding protein 5 IGFBP5 1.55 ↑ 0.72 0.022
Cell proliferation-related genes
Y12084 Cysteine-rich, angiogenic inducer, 61 CYR61 1.50 ↑ 0.53 0.007
XM_001393 Natural killer-enhancing factor A PRDX1 0.63 ↓ 0.35 0.006
Metabolism-related genes
NM_001825 Creatine kinase CKMT2 1.59 ↑ 0.65 0.009
AI494124 Selenoprotein P, plasma, 1 SEPP1 0.69 ↓ 0.36 0.015
AI207602 Hemoglobin, gamma G HBG2 0.57 ↓ 0.46 0.008
AW249010 Heat shock 70 kDa protein 10 HSPA8 0.53 ↓ 0.35 0.001
Genes with other functions and EST sequences
NM_004854 HNK-1 sulfotransferase CHST10 2.08 ↑ 1.10 0.008
AA375284 Poly (rC)-binding protein 2 PCBP2 1.64 ↑ 0.49 0.001
AI275225 MAX-like bHLHZIP protein MLX 0.64 ↓ 0.19 0.000
Z48042 Membrane surface marker 1 M11S1 0.60 ↓ 0.40 0.005
AI815757 Ribosomal protein L35 RPL35 0.48 ↓ 0.38 0.001
NM_004772 Chromosome 5 open reading frame 13 P311 0.40 ↓ 0.17 0.000
AA431300 EST6 2.24 ↑ 1.28 0.009
N92589 EST4 2.12 ↑ 1.42 0.019
N93201 EST5 2.00 ↑ 1.35 0.033
AA195902 EST14 0.66 ↓ 0.31 0.011
The signal intensities of the competitive hybridization were quantified with a two-channel (Cy3 and Cy5) fluorescence scanner. Analysis of the fluorescence intensities
and expression ratios were performed using GenePix Pro 4.1 software. Data represent the mean and SD of the Cy5/Cy3 intensity ratios (n=12). Those signal intensities
more than 2 SDs from the background intensity and greater than the negative sham control intensity were considered as acceptable signals. This table lists results for
which the differential expression was ≥1.5-fold, which was considered as significant (P<0.05).
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modulators [14–17], that showed increased expression of be-
tween 1.6- and 3.2-fold (P<0.01) (Table 2). They may
contribute to the altered transcription processes involved in the
complex remodeling during AF, but, to the best of our knowl-
edge, the transcriptional regulators associated with AF have not
been well explored.
3.3. Validation of altered gene expression by quantitative
real-time RT-PCR
Quantitative real-time RT-PCR was performed to validate the
mRNA expression results of the AF Chip. We selected four
differentially expressed genes FHL1, TSC-22, CARP, andP311. As mentioned above, P311 was of particular interest
because of its putative anti-fibrotic function, and FHL1, TSC-22
and CARP were chosen for further study because these genes
play regulatory roles in transcription and structural alterations in
cardiomyocytes [15–17]. Total RNA extracted from the RAA
and LAA of AF and SR model pigs was used in real-time RT-
PCR, and the relative mRNA expression level of each gene was
normalized to that of GAPDH mRNA. The relative FHL1,
TSC-22 and CARP mRNA expression levels in RAA with AF
were significantly upregulated 5.1-, 4.0- and 3.4-fold, respec-
tively, as compared with those in the SR RAA, and the relative
P311 mRNA in the AF RAA was significantly downregulated
by 5.6-fold compared with the SR RAA. Therefore, the trend of
mRNA expression changes as determined by real-time RT-PCR
Fig. 3. Verification of altered gene expression by quantitative real-time RT-PCR.
Comparison of results obtained with the AF Chip and quantitative real-time RT-
PCR for mRNA levels of FHL1, TSC-22, CARP and P311 during AF. Real-
time RT-PCR and AF Chip hybridizations were performed as described in
Materials and methods. Relative to the levels in the RAAwith SR, expression of
FHL1, TSC-22 and CARP mRNAs was increased by 5.1-, 4.0- and 3.4-fold,
respectively, in the parallel AF subjects. P311 mRNA expression was decreased
by 5.6-fold in AF. Bar graphs with error bars represent the means±SD (n=12 for
real-time RT-PCR and chip analysis).
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(Fig. 3).
Fig. 4 shows the comparisons of relative mRNA expression
determined by real time RT-PCR of the four selected genes in
the LAA and RAA of AF subjects. Expression of FHL1, TSC-
22 and CARP was significantly increased, and the levels were
similar in the right and left atria during AF. Interestingly, the
fold decrease in P311 mRNA expression in the LAA with AFFig. 4. Comparisons of mRNA expression in the RAA and LAAwith AF. The
cDNAs were prepared from the RAA and LAA of AF and SR groups and then
subjected to real-time PCR with gene-specific primers. The ratio of the
abundance of each transcript to that of the GAPDH transcript was calculated,
and the amount of mRNA expression in the AF group was expressed as a
relative change standardized to the control group. Bar graphs with error bars
represent the means±SD (n=6 in the SR group; n=12 in the LAA and RAA of
the AF group). *P<0.05 vs. RAA.was approximately twice that of P311 mRNA expression in the
RAA.
3.4. Increased distributions of FHL1 and CARP in the atria
with AF
To determine whether the increased FHL1 and CARPmRNA
levels also resulted in an increase in protein levels in pacing-
induced AF atria, we performed a western blotting analysis. As
shown in Fig. 5, a 2.9-fold and 1.6-fold average increase in
FHL1 and CARP, respectively, was observed in the fibrillating
atria. These FHL1 and CARP protein expression data are
consistent with the mRNA expression data of the cDNA array
and quantitative real-time RT-PCR.
For confirming the increased expression of both FHL1 and
CARP in rapid-pacing induced AF upon quantitative real-timeFig. 5. Western blot analysis of FHL1 and CARP protein expression in SR and
AF atria. Tissue homogenates (20 ìg protein/lane) from RAA with AF or SR
were separated on 10% SDS-PAGE gels and transferred to polyvinylidene
fluoride membrane. Immunoblots were incubated with antibodies specific for
FHL1, CARP or β-tubulin (A). The relative protein expression of FHL1 (B)
and CARP (C) was normalized to β-tubulin. The histograms show the means±
SD (n=6 in the SR group; n=12 in the AF group). *P<0.05 and **P<0.01,
vs. SR.
Fig. 6. Immunohistochemical assay of FHL1 and CARP protein in the atrial appendage tissues with SR (A and C) and AF (B and D). Increased FHL1 and CARP are
detectable in almost all myofibrils in the atrial myocytes and positive immunoreaction coincides with muscle striation and protein filaments in the muscle fibers in AF.
In fibrillating atria, immunostaining of FHL1 and CARP showed more abundant and disorganized (B and D). (Scale bar represents 50 μm).
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intracellular distribution of FHL1 and CARP in porcine atrial
appendage tissue with SR and AF using immunohistochemical
assay (Fig. 6). By the immunohistochemical assay, FHL1 and
CARP proteins were detectable in almost all myofibrils in atrial
myocytes and increased positive immunoreaction coincides
with muscle striated and filamentous forms in the atrial
myocytes in AF. Furthermore, the both of anti-FHL1 and-
CARP antibodies detected more diffuse cytoplasmic staining
with slightly increased nuclear localization in the fibrillating
atria (Fig. 6B and D).
3.5. Histological findings in the rapid-pacing induced AF
Histological studies were performed to identify the potential
pathological substrate underlying conduction abnormalities in
the sustained AF. Representatively histological sections from the
atria with AF and SR were stained with hematoxylin–eosin and
Masson's trichrome blue. Evidences provided by the Masson's
trichrome blue showed that endocardial fibrosis and extracel-
lular matrix proteins markedly accumulated in interstices
between cardiomyocytes in the AF atria (Fig. 7).
3.6. Selective increase of TGF-β isoform expression in the
fibrillating atria
Because increased expression of TSC-22 gene and decreased
expression of P311 gene in atrium with AF may be associated
with increased TGF-β signal activity, we examined levels of
expression of TGF-β isoforms. By real-time RT-PCR analysis,
expression of TGF-β2RNA levels were markedly increased 6.0-
fold in RAA and 8.8-fold in LAA during AF, and TGF-β1mRNAwere slightly increased respectively by 2.0-fold and 2.9-
fold, however, TGF-β3 mRNA levels were no significant
change (Fig. 8). These results indicated that a selective increase
of expression of TGF-β1 and-β2 isoforms was occurred in the
pacing-induced AF.
3.7. Effects of Ang II, isoproterenol, and H2O2 on FHL1 and
CARP mRNA expression in rat cardiac H9c2 cells
Several studies have indicated that the Ang II system,
adrenergic signal transduction and oxidative stress are associated
with the cellular signaling mechanisms in AF [6,18]. To
determine whether proarrhythmogenic substrates alter the
expression of FHL1 or CARP in cardiac myocytes, H9c2 cells
were treated with Ang II, the adrenergic agonist isoproterenol, or
H2O2, and FHL1 and CARP transcript levels were measured by
semi-quantitative RT-PCR. The cells were pre-treated with
differentiation-promotingmedium (containing 1% FCS) for 48 h
and then treated with 1 μM Ang II, 10 μM isoproterenol, or
200μMH2O2 for 12 h.FHL1 andCARP expression significantly
increased 3.1- and 3.3-fold, respectively, in the H9c2 cells
following treatment with isoproterenol, CARP expression
slightly increased with Ang II treatment, but the two genes
expression did not increase in response to H2O2 (Fig. 9).
4. Discussion
AF is a progressive and self-sustaining disease. The
processes include electrical, contractile, neurohormonal, macro-
anatomical and ultrastructural changes, and these may lead to
the vulnerability of AF over time. Many factors such as ion
channels, proteins influencing calcium homeostasis, connexins,
Fig. 7. Representative photomicrographs of atrial appendage tissue showing
fibrosis in rapid-pacing induced AF. Histological sections from the atrial
appendage tissue with SR (A) and AF (B) were stained by Masson's trichrome
blue. The blue color characteristic of collagen after Masson's trichrome staining
was obvious in interstices between cardiomyocytes in the AF atria. Sections
from sham control, when stained similarly, reflect the extracellular matrix
marked accumulation in the rapid-pacing induced fibrillating atria. (Scale bar
represents 100 μm). (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
Fig. 8. Three TGF-β isoforms mRNA levels in right and left atrial appendages
with AF compared with SR were determined by real-time RT-PCR. Differently
expressed changes of three TGF-β isoforms mRNA were observed in AF, and
upregulation of TGF-β 1 and-β 2 expression in RAA and LAA with AF were
found. Expression of TGF-β2mRNA levels were markedly increased 6.0-fold in
RAA and 8.8-fold in LAA during AF, and the changes of TGF-β1 mRNA in
RAA and LAA were increased respectively by 2.0-fold and 2.9-fold, however,
TGF-β3 mRNA levels were no significant change, when compared with SR.
(n=6 in the SR group; n=12 in the AF group). *P<0.05 vs. SR, **P<0.05 vs.
SR and † indicates P<0.05 vs. RAA.
Fig. 9. Effects of Ang II, isoproterenol, or H2O2 on the transcription levels of
FHL1 and CARP in cardiac H9c2 cells. H9c2 cells grown to 80% confluency
were treated with 1 μM Ang II, 10 μM isoproterenol (Isop), 200 μM H2O2 or
PBS (as a control) for 12 h and then RNAwas isolated for semi-quantitative RT-
PCR. The fold changes in mRNA expression of FHL1 (A) and CARP (B) were
calculated based on GAPDH as a covariate. Data represent the means±SD of
three independent experiments. *P<0.05, and **P<0.01, vs. control.
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in the molecular mechanism of AF [1,2]. In the present study, a
porcine model with sustained AF in which structural changes in
the atrium [9,10] are induced by 4 weeks of rapid atrial
depolarization was used to obtain more insight to molecular
processes of atrial remodeling. Genes involved in transcrip-
tional regulation, ion transport, signal transduction, metabolism,
cell proliferation, extracellular matrix and structural proteins,
and a few unclassified genes were used to study the differential
expression in AF via a low-density cDNA array, named AF
Chip (Fig. 1). To evaluate the threshold in differential
expression of mRNA in our AF Chip, mock hybridization of
two differentially labeled cDNAs to three replicates was first
performed. More than 98% of the visible signals revealed Cy5/
Cy3 ratios between 0.67 and 1.50 (data not shown). These ratios
were used as cut-off values to identify significant differential
expression throughout our experiments, in addition, the
consistent and reliable AF Chip processes were also confirmed
(Fig. 2). Results from the AF Chip analysis revealed that 31
mRNAs out of 84 clones were differentially expressed in atrialtissues (ratios ≥1.50 or ≤0.67; P<0.05) in the rapid pacing-
induced AF model (Table 2). Most observation of the 31 genes
included those involved in activation of signal transduction
systems, transcriptional regulation and structural alterations
326 C.-L. Chen et al. / Biochimica et Biophysica Acta 1772 (2007) 317–329characteristic of AF. These alterations in expression by AF Chip
assay might be the focal or varied changes within the atrial
tissue induced by AF, however, a locally pronounced change
might affect whole atrial function gradually like as an
arrhythmogenic substrate in AF.
Confirmatory real-time RT-PCR supported our AF Chip
findings and emphasized the marked differential expression of
the transcriptional regulator genes FHL1, CARP and TSC-22
and an anti-fibrotic gene, P311, in the LAA and RAA tissues
with AF (Figs. 3 and 4). Furthermore, FHL1 and CARP protein
levels were also confirmed by western blotting (Fig. 5).
The LIM domain of FHL1 is located at the amino terminus,
which is associated with GATA1-type zinc fingers [19], and the
role of FHL1 in transcriptional regulation was proposed [16].
Besides the function in transcriptional regulation, FHL1 has also
shown integrin-dependent localization in the nucleus, cytoske-
leton, focal adhesions and stress fibers in cardiomyocytes [20].
The CARP protein, a nuclear transcriptional co-factor that
negatively regulates cardiac gene expression [15], was upregu-
lated in human heart failure and animal models of cardiac
hypertrophy [21,22]. Witt et al. [23] demonstrated that CARP
variably localizes in the sarcoplasm and the nucleus in adult
skeletal muscle cells. There was documented that CARP
overexpression induces contractile dysfunction in an engineered
heart tissue [24].
Upon the information of molecular functions for FHL1 and
CARP, they are proposed as the critical roles in the transcrip-
tional regulation, myofibrillar assembly and even communica-
tion between sarcoplasm and nucleus in the cardiomyocytes
[20,24]. In the present study, increased expressions and
distributions of FHL1 and CARP in AF atrial myocytes were
detected, revealing that they may play a role associated
partially with structures of the striated sarcomeres and protein
filaments in AF atrial myofibrils (Fig. 6). Together these
functional studies, the increased distributions of FHL1 and
CARP might effect on atrial gene expression or contractility in
the fibrillating atria by modulating transcription and myofila-
ment assembly.
Factors that may contribute to progressive stability of AF
with changed cellular signaling in a prolonged time course, also
termed “arrhythmogenic substrates”, have been discussed [18].
Among which, abnormal neurohormonal stimuli, such as
angiotensin II (Ang II) and norepinephrine, may play a critical
role in the sustained AF. Recent reports demonstrated activation
of the renin angiotensin system (RAS) and RAS-dependent
signaling pathways by AF in atria in humans [25] and in a dog
model [26]. Ang II is an important modulator of cardiac and
cardiomyocyte contractility. Ang II has been shown to
exacerbate contractile dysfunction in experimental models of
pressure-overload cardiac hypertrophy [27] and pacing- or
infarction-induced heart failure [28,29]. In addition to RAS,
sympathetic hyperinnervation, nerve sprouting, and a hetero-
geneous increase in atrial sympathetic stimulation have also
been demonstrated in a canine model of sustained AF produced
by prolonged right atrial pacing [30]. By isoproterenol infusion,
Doshi et al. [31] demonstrated that the rapid automatic activity
trigger the onset of AF, which occurs only in the atriumharvested from dogs with long-term pacing-induced AF but not
in normal atrium. These findings underline the well-known
profibrillatory effect resulting from a local excess of catecho-
lamines [32]. The most important pattern of signal transduction
linking the sympathetic nervous system to the intracellular
effector in cardiomyocytes is mediated through the β1- and β2-
adrenoceptors. The β-adrenergic receptors are stimulated by the
catecholamines, which initiates a cascade of intracellular events
that leads to an increase in conduction velocity and shortening
of the refractory period.
Direct effect of oxidative stress on atrial remodeling in a
pacing-induced AF was also demonstrated by Carnes et al. [33].
Mihm et al. [34] found that increased oxidative stress during AF
could contribute to contractile dysfunction. Most effects of
mentioned above, neurohormonal stimuli and oxidative stress,
can be provoked by the rapid atrial pacing and appear to be of
importance for molecular changes in fibrillating atrium and
effect on atrial contractile dysfunction [26,30,33].
We speculated that the FHL1 and CARP expression may be
affected by neurohormonal stimuli and/or oxidative stress, since
the two proteins represent the roles as the transcription
regulators, myofilament components and were upregulated in
this AF mode with rapid atrial depolarization for 6 weeks.
Therefore, we were undertaken to investigate whether the
expressions of FHL1 and CARP in cardiomyocytes in vitro are
directly regulated due to these proarrhythmogenic stimulations
which were implicated in the atrial remodeling during AF. We
found that the β-adrenergic agonist isoproterenol, but not Ang II
or H2O2, significantly increased mRNA expression of both
FHL1 and CARP in H9c2 cells (Fig. 9). The rapid upregulation
of FHL1 and CARP expression in H9c2 cells stimulated by
isoproterenol showed that regulation of the two genes may be
mediated via the βAR signal transduction pathway. In the
fibrillating atria, there was also evidence that the upregulated
β2AR mRNA was observed by cDNA array analysis (Table 2);
these results implicate that upregulation of FHL1 and CARP in
the fibrillating atria might be associated with the activation of
βAR signal pathway. In the study performed by Gaussin et al.
[35], the expression of FHL1 was dramatically upregulated in
different mousemodels of overexpressingβ1AR,β2AR or PKA,
indicating that FHL1 expression is upregulated by the βAR-
PKA pathway. In addition, induced expression of CARP in
cardiomyocytes by activation of PKA and CaMK was also
obtained [24]. These studies strongly support our suggestions
that the βAR signal pathway might be activated to upregulate
two important regulators, FHL1 and CARP, and effect on the
changes of transcriptional regulation and atrial contractile in AF.
The increased expression of CARP induced by Ang II in
H9c2 cells has also been detected (Fig. 9B). Ang II affects the
expression of a wide range of signaling pathways [6]. There-
fore, we would not exclude the possibility that upregulated
expression of CARP in the pacing-induced AF model might be
partially effected by activation of RAS signal pathway.
However, the results of the in vitro experiment demonstrate
that FHL1 and CARP expression were not elevated in the
H2O2-treated H9c2 cells, suggesting that changes in FHL1 and
CARP expression may be not associated with modulation of
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These results of in vitro experiments provide a reference value
to ongoing studies of the underlying molecular mechanism and
even for novel insight in strategy of AF treatment. Nevertheless,
with only limited studies in cardiac H9c2 cells in this regard, the
results of changed FHL1 and CARP expressions associated
with cell signaling and transcription regulation in AF may be
fundamental and deserve future investigations.
Calcium overload in AF was suggested a critical factor in the
electrophysiological remodeling process and altered contraction
and signaling in cardiomyocytes [36,37]. It is commonly
believed that even minutes of rapid atrial rates can result in
intracellular calcium overload, which decreases the L-type
calcium current (ICaL) [38]. In the present study, the mRNA
expression levels of genes for L-type voltage-dependent calcium
channel alpha-1C and-1S subunits (CACNA1C and CAC-
NA1S), involved in influencing calcium homeostasis, were also
evaluated in our microarray analysis (Fig. 1). However, no
significantly different was found between the AF and sham
control groups. Our results seem to disagree with the published
literature suggesting a decrease in L-type Ca2+ channel density
that contributes to the reduction of ICaL [36]. Nevertheless,
studies on gene expression of the L-type Ca2+ channel, so far,
have reported different results in AF. Schotten et al. [39]
reported that there is no change in L-type Ca2+ channel density
in persistent AF patients. An ultrastructural calcium distribution
in goat atria with 1–16 weeks of burst-pacing-induced AF was
performed [40]. Ausma et al. [40] showed that Ca2+ overload
persists for 2 weeks, after which the cardiomyocytes apparently
adapt to a new Ca2+ homeostasis and reach normal level, and
then Ca2+ levels are below normal level after 16 weeks of AF.
This study implicated that Ca2+ overload induced by over-drive
pacing is reversible. Accordingly, we conceived that the new
Ca2+ homeostasis and even recovery expression of calcium
channel might be taken place in our AF model, which was
induced by atrial rapid pacing for 4 weeks and then maintained
AF without pacing for 2 weeks. Although the clear mechanism
of reversible downregulation of ICaL has not yet been uncovered,
the calcium channel expression might be unchanged or have be
recovery in our pacing-induced AF and play in part roles for the
new Ca2+ homeostasis. Interestingly, the mRNA expression of
calmodulin 2 (CALM 2) was increased by 1.7-fold in our AF
model (Table 2). CALM is a critical Ca2+ sensor and regulatory
protein and the formation of Ca2+/ CALM complex selectively
activates specific downstream signaling pathways in response to
local changes in calcium concentration [41]. We suggest that the
increased CALM 2 in AF might act as a critical Ca2+ sensor for
the modulatory effects on calcium channels function or down-
stream signaling and therefore to overcome the detrimental Ca2+
overload. However, much additional work in this regard, such as
the respective roles of functional (Na+, K+, Ca2+, and Cl−)
channels and the precise signaling of Ca2+/CaML, need to be
performed to truly understand the changes and effects of Ca2+
homeostasis in AF.
A number of cardiovascular diseases are associated with
extracellular matrix homeostasis [42,43]. The occurrence of
atrial fibrosis in the development of AF has been documented[44–46] and also found in our AF model (Fig. 7). Interesting, an
unclassified gene, P311, was markedly downregulated in the
fibrillating atria. Recent studies indicate that P311 blocks TGF-
β autoinduction and downregulates the expression of genes
encoding extracellular matrix proteins in cardiac myofibro-
blasts, suggesting that P311 exerts anti-fibrotic effects by
inhibiting TGF-β signaling [47]. Furthermore, TSC-22 is a
TGF-β-inducible gene and represents a transcriptional regulator
that enhances the activity of TGF-β signaling by binding to and
modulating the transcriptional activity of Smad3 and Smad4
[48]. The expression of TSC-22 was significantly induced by
4.0-fold in our AF model, implicating the enhanced activation
of TGF-β signaling in the fibrillating atria. In concordance with
our supposition, we identified the upregulated expressions of
TGF-β isoforms in the AF model by real-time RT-PCR analysis.
The expression of TGF-β2 RNA levels were markedly
increased in atrial tissues with AF and TGF-β1 RNA were
slightly increased; however, TGF-β3 RNA levels were no
significant change (Fig. 8). Interestingly, the differently
upregulated levels of TGF-β2 between RAA and LAA with
AF seemingly showed the parallel with the decreased expres-
sion of P311 in atrial tissues (Figs. 4 and 8), implicating that
effects of TGF-β2 expression in AF may at least partially result
from loss of P311 blocked TGF-β autoinduction. Recent studies
have demonstrated an upregulation of TGF-β1 expression in
human AF patients by microarray analysis, indicating activation
of TGF-β1 signaling is involved in the process of development
fibrosis in AF [3,4]. Besides, the studies on transgenic mice
have also shown that increased cardiac expression of TGF-β1
leads to atrial fibrosis [49] and increased vulnerability to AF
[50]. The upregulation of TGF-β1 and-β2 identified in the
rapid-pacing induced AF model may therefore promote the
activation of fibroblasts and atrial fibrosis. These results suggest
that the dramatic P311 downregulation and TSC-22 upregula-
tion may play a significant critical role and contribute to the
development of fibrosis during AF while the increased TGF-β1
and-β2 expression were also obtained.
In conclusion, use of a low-density cDNA array of 84 selected
genes identified four genes, FHL1, CARP, TSC-22 and P311, as
differentially expressed in the rapid-pacing induced AFmodel in
pig. The observed alterations in AF were proven by further
identification of protein expression and possible mechanism in
the fibrillating atria. These data implicated that the changes in
transcriptional regulator expressions, myofilament assembly
and genes responsible for TGF-β signaling might play a
significant functional role in AF-induced the structural altera-
tions, such as atrial contractile dysfunction and interstitial
fibrosis, and provide future avenues for investigation of the
underlying mechanisms of AF pathogenesis.
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